Book Online
or Call 1-855-SAUSALITO
Sign In
|
Register
|
About Sausalito
|
Contact Us
Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast
|
Traffic
Online Reservations
Cavallo Point
Casa Madrona
The Gables Inn
Mill Valley Inn
Acqua Hotel
Larkspur Hotel
Waters Edge
The Lodge at Tiburon
Sausalito Hotels
Vacation Packages
San Francisco Hotels
Event Calendar
Art Galleries
Arts and Culture
Amusement Parks
Nightlife
Attractions
Sausalito Ferry
Public Parks
Entertainment
Movie Show Times
TV Listings
Celebrities on TV
Museums and Historical Places
Environmental
Food and Wine
Day Trips
Visit San Francisco
Spas and Massage
Apartments
Arts, Culture, & Entertainment
Amusement and Water Parks
Art Galleries & Dealers
Art Instruction & Schools
Attractions
Environmental
Food and Wine Entertainment
Marin Arts and Culture
Movie Theaters & Movie Rentals
Museums
Music Venues
Photographers
Photography - Commercial
Automotive
Auto Glass & Detailing
Auto Repair Service
Gas Stations
New & Used Car Dealers
Boating
Boat Rides
Boat Storage
Boats & Chartered Boats
Harbors, Marinas & Yacht Clubs
Private Yacht Clubs
Business & Professional Services
Employment Agencies
Industrial Supplies & Services
Insurance Agents & Agencies
Mailing & Shipping
Photography - Commercial
Private Investigators
Rubbish & Garbage Removal
Security Systems
Self Storage
Community & City Services
Chamber of Commerce
City & County Government
City Hall
City Maps & Guides
City of Sausalito
Community Centers
Fire Department
Library
Police Department
Post Offices
State Government
Construction and Contractors
Architects
General Contractors
Home Remodeling
Landscaping
Plumbers
Education and Schools
Nursery Schools & Kindergarten
Private Schools
Public Schools
Tutoring
Financial and Legal Services
Accountants & Tax
Banks
Bookkeeping
Financial Consultants
Lawyers & Attorneys at Law
Public Notaries
Health & Child Care
Acupuncture / Alternative Medicine
Child Protective Services
Chiropractors
Day Care
Dentists
Doctors, Physicians & Surgeons
Eye Care
Health Care Professionals
Home Health Care
Hospitals & Clinics
Hypnotherapy
Medical Equipment
Physical Therapists
Psychiatrists & Therapists
Specialists
Home and Garden
Cleaning Services
Doors & Windows
Floor Coverings
Interior Design
Landscaping
Moving Companies
Pools, Spas & Saunas
Remodeling
Media
Local TV Stations
Magazine Publishers
Newspapers
Online Publications
Print Publications
Radio Stations
Nightclubs & Music
Organizations, Foundations, & Associations
Business/Professional
Charitable Foundations
Common Interest Groups
Non-Profits
Youth Organizations
Pets
Dog & Cat Grooming
Kennels & Pet Boarding
Pet Hospitals
Pet Supplies
Veterinarians
Real Estate
Apartments
Appraisers
Commercial Development
Commercial Management
Commercial Real Estate
Construction
Developers
Mortgage Brokers
Property Management
Residential Real Estate
Religion
Restaurants, Food & Bars
American
Bakery
Breakfast
Burgers
Chinese
Coffee & Caf�s
Deli
Fast Food
Free Wi-Fi
French
Himalayan
Ice Cream / Frozen Yogurt
Indian
Italian
Mexican
Ocean View Restaurants
Pizza
Seafood
Sports Bars
Steakhouse
Sushi
Thai Food
Wine Tasting Room
Salons, Spas, & Fitness
Barbers
Beauty Salons
Cosmetics
Fitness Equipment
Gyms & Health Clubs
Manicures & Pedicures
Massages
Personal Trainers
Spas
Waxing
Sausalito Hotels & Inns
Bed & Breakfasts
Hotels, Motels & Resorts
Vacation Rentals
Shopping
Book Stores
Children's Clothing
Electronics
Florists
Furniture & Appliances
Gifts & Specialty Shops
Grocery Stores
Handbags
Jewelers
Marin County Shopping Centers
Men & Women's Clothing
Men's Clothing
Shoes
Sportswear
Women's Clothing
Yoga
Sports and Recreation
Bicycle Rentals & Retailers
Boats & Chartered Boats
Kayaking
Public Parks
Walking Trails
Technology & Utility Services
Computer Parts & Supplies
Computer Repair
Electric Companies
Internet Service Providers
Telephone & Cable Companies
Website Development & Design
Travel and Transportation
Airport Transportation
Bike Rentals
Buses Charter & Rental
Ferry
Limo Car Services
Taxi Cabs
Travel Agencies
Weddings
Caterers
Planners
Venues
Wi-Fi Hotspots
Your Business Here
Ferry Schedule
Surf Report
Coupons
Contests
Classifieds
Site Forums
Photo Gallery
Story Archives
Advertise With Us
Free Email
Send Flowers
Search Hotels in Sausalito
CHECK-IN:
CHECK-OUT:
ROOMS:
1
2
3
4
Find A Business
or
Browse Listings
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Praxis Precision Medicines, Inc. - Common Stock
(NQ:
PRAX
)
332.83
-0.44 (-0.13%)
Streaming Delayed Price
Updated: 2:54 PM EDT, May 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Praxis Precision Medicines, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Praxis Precision Medicines (NASDAQ:PRAX) Beats Q1 Estimates as FDA Accepts Two Key Drug Applications
↗
May 07, 2026
Via
Chartmill
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2026 Financial Results
May 07, 2026
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 05, 2026
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference
May 04, 2026
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Praxis Precision Medicines Announces FDA Acceptance of New Drug Application for Ulixacaltamide HCl in Patients with Essential Tremor
April 14, 2026
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Praxis to Showcase Essential3, the First Positive Phase 3 Program in Essential Tremor, at AAN 2026
April 13, 2026
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Praxis Precision Medicines Announces Positive Results from the EMBRAVE Part A Trial of Elsunersen in Patients with SCN2A Early-Onset Developmental and Epileptic Encephalopathy
April 06, 2026
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 02, 2026
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Praxis Precision Medicines Announces FDA Acceptance and Priority Review of New Drug Application for Relutrigine in Patients with SCN2A and SCN8A DEEs
March 30, 2026
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Structure Therapeutics Slides 28% This Year as $6 Million Stake Emerges
↗
March 22, 2026
Structure Therapeutics advances oral therapies for diabetes, obesity, and pulmonary disease through its clinical-stage drug pipeline.
Via
The Motley Fool
Biotech Stock Still Up 700% Despite 30% Drop This Year as One Fund Discloses $9 Million Exit
↗
March 18, 2026
This Boston-based biotech develops therapies for neurological disorders, with a pipeline targeting depression, tremor, and rare epilepsies.
Via
The Motley Fool
This Fund Bought $28 Million of a Beaten-Down Immunotherapy Stock Last Quarter. What Should Long-Term Investors Know?
↗
March 16, 2026
This biotech develops Nanobody-based therapies targeting chronic inflammatory diseases in dermatology and rheumatology markets.
Via
The Motley Fool
Topics
Regulatory Compliance
This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal
↗
March 16, 2026
Arcellx develops cell-based immunotherapies for cancer, leveraging proprietary platforms to address high unmet needs in oncology.
Via
The Motley Fool
Topics
Regulatory Compliance
Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch
↗
March 16, 2026
Olema Pharmaceuticals develops targeted therapies for women's cancers, with a lead candidate in clinical trials for breast cancer treatment.
Via
The Motley Fool
Topics
Regulatory Compliance
This Biotech Stock Up 700% Is Still a Top Holding Despite a $9.3 Million Sale Last Quarter
↗
March 16, 2026
Praxis Precision Medicines develops clinical-stage therapies for neurological disorders, targeting major unmet needs in CNS therapeutics.
Via
The Motley Fool
Topics
Regulatory Compliance
A Healthcare Hedge Fund Just Added $24.5 Million in Immunovant Stock. Should you?
↗
March 15, 2026
This clinical-stage biotech develops antibody therapies targeting autoimmune diseases, with a lead candidate in Phase II trials.
Via
The Motley Fool
This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision
↗
March 13, 2026
Vera Therapeutics develops biologic therapies for serious immunological diseases, with a pipeline targeting high-burden conditions.
Via
The Motley Fool
Topics
Regulatory Compliance
Inside One Fund's $170 Million Bet on a Biotech Stock Up 1,040% in a Year Amid FDA Review for Breast Cancer Drug
↗
March 13, 2026
Celcuity develops targeted cancer therapies and diagnostics, leveraging proprietary technology to advance precision oncology solutions.
Via
The Motley Fool
Topics
Regulatory Compliance
Praxis Stock Has Surged 700% in a Year, and This Fund Is Betting $266 Million on Its Pipeline
↗
March 13, 2026
Praxis Precision Medicines develops therapies for central nervous system disorders, targeting unmet needs in neurology and psychiatry.
Via
The Motley Fool
This Fund Has a $200 Million Bet on a Biotech Stock Up 30% in Days After Phase 3 Breakthrough
↗
March 13, 2026
This biotech specializes in therapies for neurological disorders, advancing a diverse pipeline through late-stage trials and collaborations.
Via
The Motley Fool
Topics
Regulatory Compliance
Battery Storage Stock Up 50% in a Year Draws New $110M Investment. Here's What You Should Know
↗
March 13, 2026
This energy storage firm develops battery solutions for utility and commercial clients, targeting grid-scale renewable energy markets.
Via
The Motley Fool
Topics
Regulatory Compliance
Biotech Stock Up 685% Draws $80.5 Million Investment Amid Dual FDA Filings
↗
March 13, 2026
Praxis Precision Medicines focuses on clinical-stage therapies for central nervous system disorders, targeting unmet needs in neurology.
Via
The Motley Fool
Topics
Regulatory Compliance
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 04, 2026
From
Praxis Precision Medicines, Inc.
Via
GlobeNewswire
Investor Buys Up $81 Million in Praxis Stock as Shares Soar Over 300% in One Year
↗
February 23, 2026
Praxis Precision Medicines develops therapies for neurological and psychiatric disorders, aiming to address unmet needs in the CNS market.
Via
The Motley Fool
Topics
Regulatory Compliance
Praxis Stock Surges 320% as One Biotech Investor's Buy Pushes Stake to Nearly $600 Million
↗
February 22, 2026
Praxis Precision Medicines targets neurological and psychiatric disorders with a pipeline of precision therapies for CNS conditions.
Via
The Motley Fool
Topics
Regulatory Compliance
Celcuity Stock Soars 700% in a Year as One Investor's $17 Million Buy Helps Create Top Two Position
↗
February 22, 2026
Celcuity develops targeted cancer therapies and diagnostic platforms, with a focus on advancing precision medicine in oncology.
Via
The Motley Fool
Apogee Shares Up Nearly 100% in 12 Months, and This $62 Million Buy Signals Ongoing Conviction
↗
February 22, 2026
Apogee Therapeutics develops biologic therapies targeting dermatology and respiratory conditions, with lead candidates in clinical trials.
Via
The Motley Fool
Topics
Regulatory Compliance
$80 Million Arcellx Sale Follows Steep Stock Drop as Rival Drug Emerges
↗
February 22, 2026
Arcellx develops next-generation cell therapies targeting multiple myeloma and other hematologic cancers in the biotechnology sector.
Via
The Motley Fool
Topics
Regulatory Compliance
Praxis Precision Shares Rally On Price Target Hikes: Analyst Sees Upside As High As 100% For Stock
↗
February 20, 2026
Praxis said on Thursday that it made two submissions earlier this year to the FDA, seeking clearance to market ulixacaltamide for the treatment of essential tremor and relutrigine for the treatment of...
Via
Stocktwits
Praxis Medicines Q4 2025 Earnings Call Transcript
↗
February 19, 2026
Praxis Medicines Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Economy
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
About Us
|
Contact Us
|
Privacy Policy
|
User Agreement
|
Advertise With Us
|
Site Map
Sausalito Home
|
Lodging
|
Sausalito Restaurants
|
Things To Do
|
Sausalito Events Calendar
|
Shopping
|
Sausalito Real Estate
|
Sausalito Directory Listings
|
Sausalito Blog
|
Jobs
|
More
Photos copyright by
Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.
